                         SEQUENCE LISTING

<110>  Trustees of Dartmouth College
       Mulligan-Kehoe, Mary Jo
 
<120>  METHODS FOR TREATING TISSUE FIBROSIS

<130>  DC0534WO

<150>  US 61/867,801
<151>  2013-08-20

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  181
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Met Gly Pro Trp Asn Lys Asp Glu Ile Ser Thr Thr Asp Ala Ile Phe 
1               5                   10                  15      


Val Gln Arg Asp Leu Lys Leu Val Gln Gly Phe Met Pro His Phe Phe 
            20                  25                  30          


Arg Leu Phe Arg Ser Thr Val Lys Gln Val Asp Phe Ser Glu Val Glu 
        35                  40                  45              


Arg Ala Arg Phe Ile Ile Asn Asp Trp Val Lys Thr His Thr Lys Gly 
    50                  55                  60                  


Met Ile Ser Asn Leu Leu Gly Lys Gly Ala Val Asp Gln Leu Thr Arg 
65                  70                  75                  80  


Leu Val Leu Val Asn Ala Leu Tyr Phe Asn Gly Gln Trp Lys Thr Pro 
                85                  90                  95      


Phe Pro Asp Ser Ser Thr His Arg Arg Leu Phe His Lys Ser Asp Gly 
            100                 105                 110         


Ser Thr Val Ser Val Pro Met Met Ala Gln Thr Asn Lys Phe Asn Tyr 
        115                 120                 125             


Thr Glu Phe Thr Thr Pro Asp Gly His Tyr Tyr Asp Ile Leu Glu Leu 
    130                 135                 140                 


Pro Tyr His Gly Asp Thr Leu Ser Met Phe Ile Ala Ala Pro Tyr Glu 
145                 150                 155                 160 


Lys Glu Val Pro Leu Ser Ala Leu Thr Asn Ile Leu Ser Ala Gln Leu 
                165                 170                 175     


Ile Ser His Trp Lys 
            180     


<210>  2
<211>  181
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Met Gly Pro Trp Asn Lys Asp Glu Ile Ser Thr Ala Asp Ala Ile Phe 
1               5                   10                  15      


Val Gln Arg Asp Leu Lys Leu Val Gln Gly Phe Met Pro Tyr Phe Phe 
            20                  25                  30          


Arg Leu Phe Arg Thr Thr Val Lys Gln Val Asp Phe Ser Glu Met Asp 
        35                  40                  45              


Arg Ala Arg Phe Ile Ile Asn Asp Trp Val Lys Arg His Thr Lys Gly 
    50                  55                  60                  


Met Ile Asn Asp Leu Leu Gly Gln Gly Ala Val Asp Gln Leu Thr Arg 
65                  70                  75                  80  


Leu Val Leu Val Asn Ala Leu Tyr Phe Asn Gly Gln Trp Lys Thr Pro 
                85                  90                  95      


Phe Pro Glu Lys Ser Thr His His Arg Leu Phe His Lys Ser Asp Gly 
            100                 105                 110         


Ser Thr Val Ser Val Pro Met Met Ala Gln Thr Asn Lys Phe Asn Tyr 
        115                 120                 125             


Thr Glu Phe Ser Thr Pro Asp Gly His Tyr Tyr Asp Ile Leu Glu Leu 
    130                 135                 140                 


Pro Tyr His Gly Asn Thr Leu Ser Met Phe Ile Ala Ala Pro Tyr Glu 
145                 150                 155                 160 


Lys Glu Val Pro Leu Ser Ala Leu Thr Ser Ile Leu Asp Ala Gln Leu 
                165                 170                 175     


Ile Ser Gln Trp Lys 
            180     


